Winklhofer-Roob, B M <br/><br/>
Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations.  [electronic resource] 

 -  The American journal of clinical nutrition  May 1996 
 - 722-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9165 
<br/><br/><label>Standard No.: </label>10.1093/ajcn/63.5.722  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Antioxidants--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cholesterol--blood<br/>Cystic Fibrosis--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Infant<br/>Liver Diseases--complications<br/>Male<br/>Time Factors<br/>Tocopherols<br/>Vitamin E--administration & dosage<br/>Vitamin E Deficiency--etiology<br/>alpha-Tocopherol--analogs & derivatives